The effects of orally administered trazodone on ambulation and recumbency in healthy horses
Journal of Veterinary Internal Medicine · 2023
DOI: 10.1111/jvim.16821 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, 2023. Written by Kallie Hobbs and 9 co-authors. Institution: Department of Large Animal Clinical Sciences, University of Florida College of Veterinary Medicine, Gainesville, Florida, USA. Major MEDLINE topics: Trazodone, Selective Serotonin Reuptake Inhibitors. Cited 4 times so far (Crossref); 19 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Trazodone, a serotonin receptor antagonist and reuptake inhibitor, might be a useful adjunctive treatment in the initial management of horses with acute laminitis if it minimizes ambulation or encourages recumbency.
Objectives
(1) Evaluate the effects of PO trazodone on ambulatory activity and recumbency in healthy horses; and (2) assess the pharmacokinetics of multiple PO doses of trazodone. Animals/Methods In a randomized cross-over design, 8 healthy horses received placebo or trazodone at 2 doses (2.5 and 7.5 mg/kg) PO q12h for 48 hours with a 14-day washout period between treatments. Forelimb step frequency was measured using a hoof-mounted accelerometer and continuous video monitoring was used to detect recumbency. Groups were compared using repeated measures analysis of variance with Tukey's post hoc test. Trazodone and m-chlorophenylpiperazine (m-CPP) plasma concentrations were determined by ultra-high performance liquid chromatography-tandem mass spectrometry and pharmacokinetics were analyzed using noncompartmental methods.
Results
Step frequency was lower in horses receiving 7.5 mg/kg trazodone than in the control group (mean step reduction: 44% ± 11%). Steps-area under the curve were significantly lower in the 7.5 mg/kg group (mean ± SD: 3375 ± 525 steps × hour) as compared to the 2.5 mg/kg group (mean ± SD: 5901 ± 2232; P = .02) and compared to control (mean ± SD: 6590 ± 1241; P = .001). No difference was found in the number of recumbent episodes (P = .92) or total duration of recumbency (P = .9). Trazodone and m-CPP achieved steady-state concentrations, with an accumulation ratio of 1.45 ± 0.2. Conclusions and Clinical Importance Although it did not affect recumbency, trazodone at 7.5 mg/kg q12h decreased step frequency by approximately 44%.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Large Animal Clinical Sciences, University of Florida College of Veterinary Medicine, Gainesville, Florida, USA.
- Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, USA.
- Department of Clinical Studies-New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, Pennsylvania, USA.
ORCID profiles: Kallie Hobbs, Daniela Luethy, Jennifer Davis, Darko Stefanovski, Andrew van Eps
Cite
APA
Hobbs, K., Luethy, D., Davis, J., Mallicote, M., Torcivia, C., Kulp, J., Stefanovski, D., Futterman, C., Cooper, F., & van Eps, A. (2023). The effects of orally administered trazodone on ambulation and recumbency in healthy horses. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16821
Vancouver
Hobbs K, Luethy D, Davis J, Mallicote M, Torcivia C, Kulp J, et al. The effects of orally administered trazodone on ambulation and recumbency in healthy horses. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16821
BibTeX
@article{Hobbs2023,
author = {Hobbs, Kallie and Luethy, Daniela and Davis, Jennifer and Mallicote, Martha and Torcivia, Catherine and Kulp, Jeaneen and Stefanovski, Darko and Futterman, Catherine and Cooper, Freya and van Eps, Andrew},
title = {The effects of orally administered trazodone on ambulation and recumbency in healthy horses},
journal = {Journal of Veterinary Internal Medicine},
year = {2023},
doi = {10.1111/jvim.16821}
}
EUVIMED